A cMet Inhibitor Promotes the Survival and Long‐Term Efficacy of Transplanted Hepatic Stem/Progenitor Cells in Liver Cirrhosis
Stem Cells International · 2026-01 · 2026 (1)
DOI: 10.1155/sci/7020341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells International, online erschienen am 30.10.2026. Verfasst von Min Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Special Medicine Shanxi Medical University Taiyuan City 030001 Sanxi Province China sxmu.edu.cn. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Capital Medical University, National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Poor retention of transplanted stem cells in the liver cirrhosis milieu (LCM) which critically blunts long‐term efficacy, remains unexplained. This study investigated the effects of a small peptide chemical compound (icMet) delivered intravenously for cMet receptor inhibition at the diethylnitrosamine (DEN)‐induced middle‐to‐late cirrhotic liver stage (CLS 8/9 ), focusing on apoptosis prevention, endogenous hepatic regeneration and the long‐term efficacy of transplanted hepatic stem/progenitor cells (MLpvNG2 cells).
Methods
C57BL/6 mice with CLS 8/9 liver injury were used as recipients. icMet was used before or during MLpvNG2 cell therapy. Tissues from CLS 8/9 livers were also used to generate conditioned medium (CM, CLS 8/9 CM) to observe MLpvNG2 cell activity in response to the injured liver‐related cues.
Results
Compared with CLS 8/9 mice without icMet, mice subjected to icMet administration showed increased survival rates of transplanted MLpvNG2 cells in the CLS 8/9 livers, as well as enhanced downstream hepatic repair and long‐term healing. In CLS 8/9 CM cultures, the survival of MLpvNG2 cells within icMet was similar to that observed in CLS 8/9 livers. In terms of the underlying mechanisms, it is possible that icMet pretreatment promotes proliferation and prevents apoptosis of grafted MLpvNG2 cells, activating host hepatic functional differentiation, particularly sinusoidal reconstruction, which can initiate hepatocyte regeneration. In addition, the relieved fibrotic load could also favor repopulation by donor cells, leading to long‐term treatment efficacy.
Conclusions
A strategy involving a pre‐ or during cell treatment that blocks the cMet receptor achieves apoptosis resistance of transplanted MLpvNG2 cells in the LCM and promotes endogenous hepatic regeneration, leading to long‐term treatment efficacy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Special Medicine Shanxi Medical University Taiyuan City 030001 Sanxi Province China sxmu.edu.cn.
- College of Bioengineering Chongqing University Chongqing City 400044 China cqu.edu.cn.
- Hepatobiliary Institute Southwest Hospital Army Medical University Chongqing City 400038 China tmmu.edu.cn.
- Beijing Key Laboratory Research on Liver Regeneration and Artificial Liver Transplantation Beijing You'an Hospital Capital Medical University Beijing City 100069 China ccmu.edu.cn.
- Department of Hepatobiliary Surgery Chongqing Hygeia Hospital Chongqing City 401147 China.
ORCID-Profile: Hongbo Shi, Lianhua Bai
Förderung
- National Natural Science Foundation of China
- Capital Medical University
- National Key Research and Development Program of China
Zitieren
APA
Yan, M., Hu, D., Lai, J., Chen, Q., Yu, J., Ding, M., Li, L., Shi, H., Zhang, H., Chen, Y., & Bai, L. (2026). A cMet Inhibitor Promotes the Survival and Long‐Term Efficacy of Transplanted Hepatic Stem/Progenitor Cells in Liver Cirrhosis. Stem Cells International, 2026(1). https://doi.org/10.1155/sci/7020341
Vancouver
Yan M, Hu D, Lai J, Chen Q, Yu J, Ding M, et al. A cMet Inhibitor Promotes the Survival and Long‐Term Efficacy of Transplanted Hepatic Stem/Progenitor Cells in Liver Cirrhosis. Stem Cells International. 2026;2026(1). doi:10.1155/sci/7020341
BibTeX
@article{Yan2026,
author = {Yan, Min and Hu, Deyu and Lai, Jiejuan and Chen, Quanyu and Yu, Jiayu and Ding, Mei and Li, Lu and Shi, Hongbo and Zhang, Hongyu and Chen, Yu and Bai, Lianhua},
title = {A cMet Inhibitor Promotes the Survival and Long‐Term Efficacy of Transplanted Hepatic Stem/Progenitor Cells in Liver Cirrhosis},
journal = {Stem Cells International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/sci/7020341}
}
EUVIMED